2018 - 5 Issue

Review

Ocular Manifestations of Granulomatosis with Polyangiitis

Eva Říhová
Petra Svozílková ORCID – Michaela Brichová ORCID – Aneta Klímová ORCID – Pavel Kuthan – Pavel Diblík

Full Text links

DOI: 10.31348/2018/5/1

Published in Czech and Slovak Ophtalmology: 2018 - 5

Published on website: 27.03.2019

Keywords: Granulomatosis with polyangiitis (GPA), orbit, scleritis, peripheral ulcerative keratitis (PUK), immunomodulation

Summary

Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is an autoimmune vasculitis of small vessels, presenting as necrotizing granulomatous inflammation especially of the upper and lower respiratory tract and necrotizing glomerulonephritis. GPA affects more often Caucasians in northern states, predominantly is affected the age-range group of 50 – 60 years. GPA may affect any organ; the eye symptoms are stated in the range of 16–78 %. The eye symptoms are very variable, and in up to 27 % they are the first sign of undiagnosed GPA. The etiology of GPA was not until now explained. Anti-neutrophil cytoplasmic antibodies (ANCA) play important role in the pathogenesis of this disease. GPA is ranked among ANCA associated vasculitis. The GPA is diagnosed on the basis of clinical signs and symptoms of systemic vasculitis, laboratory and histological tests and imaging studies. Immunomodulative therapy made a contribution to the improvement of GPA prognosis in the last decades; biological treatment reaches the prominence of the GPA treatment procedures. Good collaboration with other specialties is necessary for the early diagnosis and treatment of this life and vision threating disease. The ophthalmologist in the collaboration with specialists of other medical branches may take an important part in the GPA diagnostics, monitoring of the disease’s course, or adverse affects of the medication.

This paper pays attention to the eye symptoms of the GPA; the literature is supplemented with own photographs of GPA eye symptoms in patients followed up at the Department of Ophthalmology, First medical faculty, Charles University and General Faculty Hospital in Prague, Czech Republic, E.U.

References

  1. Alloway, JA., Cupps, TR.: High–dose methylprednisolone for retro-orbital Wegener‘s granulomatosis. J Rheumatol. 20(4); 1993: 752-754.
  2. Banerjee, SH., Grayson, PC.: Vasculitis Around the World: Epi - demiologic insights into causality and a need for global partnership. J Rheumatol. 44(2); 2017: 136-139.
  3. Bertelmann, E., Liekfeld, A., Pleyer, U. et al.: Cytomegalovirus retinitis in Wegener‘s granulomatosis: case report and review of the literature. Acta Ophthalmol Scand. 83(2); 2005: 258-261.
  4. Blaise, P., Robe-Collignon, N., Andris, C. et al.: Wegener granulomatosis and posterior ischemic optic neuropathy. Eur J Intern Med. 18(4); 2007: 326-327.
  5. Charles, SJ., Meyer, PA., Watson, PG.: Diagnosis and management of systemic Wegener‘s granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol. 75(4); 1991: 201-207.
  6. Charlier, C., Henegar, C., Launay, O. et al.: Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis. 68(5); 2009: 658-663.
  7. Chiquet, C., Lumbroso, L., Denis, P. et al.: Acute posterior multifocal placoid pigment epitheliopathy associated with Wegener‘s granulomatosis. Retina 19(4); 1999: 309-313.
  8. Cocho, L., Gonzales-Gonzales, LA., Molina-Prat, N. et al.: Scleritis in patients with granulomatosis with polyangiitis (Wegener). Br J Ophthalm. 100(8); 2016: 1062-1065.
  9. Courcoutsakis, NA., Langford, CA., Sneller, MC. et al.: Orbital involvement in Wegener‘s granulomatosis: MR findings in 12 patients. J Comput Assist Tomogr. 21(3); 1997: 452-458.
  10. Cutler, WM., Blatt, IM.: The ocular manifestations of lethal midline granuloma (Wegener‘s granulomatosis). Am J Ophthalmol. 42(1); 1956: 21-35.
  11. de Silva, DJ., Cole, C., Luthert, P. et al.: Masked orbital abscess in Wegener‘s granulomatosis. Eye 21(2); 2007: 246-248.
  12. Fortney, AC., Chodosh, J.: Conjunctival ulceration in recurrent Wegener granulomatosis. Cornea 21(6); 2002: 623-624.
  13. Foster, CS.: Peripheral ulcerative keratitis in Melki SA., Fava LA.: Cornea and refractery atlas of clinical wisdom, chapter 17, 2011, SLACK corp, print, USA.
  14. Freeman, WR., Stern, WH., Gross, JG. et al.: Pathologic observations made by retinal biopsy. Retina. 10(3); 1990: 195-204.
  15. Freidlin, J., Wong, I.G., Acharya, N.: Rituximab treatment for peripheral ulcerative keratitis associated with Wegener‘s granulomatosis. Br J Ophthalmol. 91(10); 2007: 1414-1416.
  16. Greco, A., Marinelli, C., Fusconi, M. et al.: Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopath and Pharmacol. 29(2); 2016: 151-159.
  17. Harper, SL., Letko, E., Samson, CM. et al.: Wegener‘s granulo - matosis: the relationship between ocular and systemic disease. J Rheumatol. 28(5); 2001: 1025-1032.
  18. Hejcmanová, D., Koblížek, V., Ruta, J.: Wegenerova granulomatóza - kazuistické sdělení, Cesk Slov Oftalmol, 63(1); 2007: 55-62.
  19. Hoffman, GS., Kerr, GS., Leavitt., RY. et al.: Wegener‘s granulomatosis: an analysis of 158 patients. Ann Intern Med. 116(6); 1992: 488-498.
  20. Huong du, LT., Tran, TH., Piette, JC.: Granulomatous uveitis re - vealing Wegener‘s granulomatosis. J Rheumatol. 33(6); 2006: 1209-1210.
  21. Jabs, DA., Mudun A., Dunn J.P. et al.: Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 130(4); 2000: 469–476.
  22. Kalina, PH., Lie, JT., Campbell. RJ. et al.: Diagnostic value and limitations or orbital biopsy in Wegener‘s granulomatosis. Ophthalmology 99(1); 1992: 120-124.
  23. Kamei, M., Yasuhara, T., Tei, M. et al.: Vitreous hemorrhage from a ciliary granuloma associated with Wegener granulomatosis. Am J Ophthalmol. 132(6); 2001: 924-926.
  24. Kubaisi, B., Abu Samra, K., Foster, CS.: Granulomatosis with polyangiitis: an apdated rewiev of ocular disease manifestation. Intractable Rare Dis Res. 5(2); 2016: 61-69.
  25. Lasave, AF., You, C., Ma, L. et al.: Long-term outcomes of rituximab therapy in patients with noninfectious posterior uveitis refractory to conventional immunosuppressive therapy. Retina 38(2); 2018: 395-402.
  26. Leavitt, RY., Fauci, AS., Bloch, DA. et al.: The American College of Rheumatology 1990 criteria for the diagnosis of Wegener‘s granulomatosis. Arthritis Rheum. 33(8); 1990: 1101- 1107.
  27. Levi, M., Kodsi, SR., Rubin, SE. et al.: Ocular involvement as the initial manifestation of Wegener‘s granulomatosis in children. J AAPOS. 12(1); 2008: 94-96.
  28. Lida, T., Spaide, RF., Kantor, J.: Retinal and choroidal arterial occlusion in Wegener‘s granulomatosis. Am J Ophthalmol. 133(1); 2002: 151-152.
  29. Lošťáková, V., Kolek, V., Vašáková, M. et al.: Granulomatóza s polyangiitidou (Doporučený postup při diagnostice, terapii a sledování vývoje onemocnění) [KAP. 6.4] Sekce intersticiálních plicních procesů ČPFS – dostupné na www.pneumologie.cz
  30. Lukáš, J., Hroboň, M., Rambousek, P. et al.: Lokalizovaná forma Wegenerovy granulomatozy s postižením ucha a oka. Otolaryng Foniat. 52(1); 2003: 29-32.
  31. Lutalo, MK., DCruz, DP.: Diagnosis and classification of granu - lomatosis with polyangiitis. J Autoimun. 48-49; 2014: 94-98.
  32. Martínková, K., Valkovský, I., Handlos P.: Granulomatóza s polyangiitidou. Interni Med. 16(5); 2014: 199-201.
  33. Masuda, T., Izumi, Y., Takeshita, H. et al.: Granulomatosis with polyangiitis presenting as a choroidal tumor. Case Rep Rheumatol. 2015; 2015: 271823. doi: 10.1155/2015/271823.
  34. McNab, AA.: The 2017 Doyne Lecture: the orbit as a window to systemic disease. Eye (Lond). 32(2); 2018: 248-261.
  35. Messme, EM., Foster, CS.: Vasculitic peripheral ulcerative ke - ratitis. Surv Ophthalmol. 43(5); 1999: 379-396.
  36. Metee, A., Kimyon, S., Saygili, O. et al .: Bilateral acute angle-closure glaucoma as a first presentation of granulomatosis with polyangiitis (Wegener’s) Arq Bras Oftalmol. 79(5); 2016: 336-338.
  37. Meyer, PA., Watson, PG., Franks, W. et al.: Pulsed immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease. Eye (Lond) 1(4); 1987: 487-495.
  38. Mohammad, AJ., Jacobsson LT., Westman, KW. et al.: Incidence and survival rates in Wegener‘s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12); 2009: 1560-1565.
  39. Muller, K., Lin, JH.: Orbital granulomatisis with polyangii - tis: clinical and pathological findings. Arch Pathol Lab Med. 138(8); 2014: 1110-1114.
  40. Eloy, P., Leruth, E., Bertrand, B. et al.: Successful endonasal dacryocystorhinostomy in a patient with Wegener‘s granulomatosis. Clin Ophthalmol. 3; 2009: 651-656.
  41. O‘Donoghue, E., Lightman, S., Tuft, S. et al.: Surgically induced necrotising sclerokeratitis (SINS) -precipitating factors and response to treatment. Br J Ophthalmol. 76(1); 1992: 17-21.
  42. Pagnoux, C., Mahr, A., Hamidou, MA. et al.: Azathioprine or methotrexat maintenance for ANCA-associated vasculitis. N Engl J Med. 359(26); 2008: 2790-2803.
  43. Pakalniskis, MG., Berg, AD., Policeni, BA.: The Many Faces of granulomatosis with polyangiitis: A review of the head and neck imaging manifestations. Am J Roentgenol. 205(6); 2015: 619-629.
  44. Phillip, R., Luqmani. R.: Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 26(5); 2008: 94-104.
  45. Pakrou, N., Selva, D., Leibovitch, I.: Wegener‘s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 35(5); 2006: 284-292.
  46. Reinhold-Keller, E., Beuge, N., Latza, U. et An indesciplinary approach to the care of patients with Wegenerś granulomatosis. Long-Term Outcome in 155 Patients. Arthritis Rheum. 43(5); 2000: 1021-1032.
  47. Říhová, E., Havlíková, M., Michalová, K. et al.: Diagnóza a léčba Wegenerovy granulomatózy na podkladě očních změn. Cesk Slov Oftalmol. 53(4); 1997: 223-228.
  48. Salam, A., Meligonis, G., Malhotra, R.: Superior oblique myositis as an early feature of orbital Wegener‘s granulomatosis. Orbit 27(3); 2008: 203-206.
  49. Santiago, YM., Fay, A.: Wegener‘s granulomatosis of the orbit: a review of clinical features and updates in diagnosis and treatment. Semin Ophthalmol. 26(4-5); 2011: 349-355.
  50. Seo, P., Specks, U., Keogh, KA.: Efficacy of rituximab in limi - ted Wegener‘s granulomatosis with refractory granulomatous manifestations. J Rheumatol. 35(10); 2008: 2017-2023.
  51. Soukiasian, SH.: Wegeners granulomatosis in Foster et Vitale: Diagnosis and treatment of uveitis. Saunders company, Philadelphia, 2011: 661-672.
  52. Svozílková, P., Říhová, E., Brichová, M. et al.: Infliximab v léčbě Wegenerovy granulomatózy. Cesk Slov Oftalmol, 62(4); 2006: 280-286.
  53. Talar-Williams, C., Sneller, M.C., Langford, C.A. et al.: Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener‘s granulomatosis. Br J Ophthalmol. 89(4); 2005: 493-497.
  54. Tarabishy, AB., Schulte, M., Papliodis, GN. et al.: Wegeners granulomatosis: Clinical manifestations, differential diagnosis and management of ocular and systemic disease. Surv Ophthalmol. 55(5); 2010: 429-443.
  55. Taylor SR., Salama, AD., Joshi, L et al.: Rituximab is effective in the treatment of refractory ophthalmic Wegener‘s granulomatosis. Arthritis Rheum. 60(5); 2009: 1540-47.
  56. Vogiatzis, KV.: Bilateral blindness due to necrotizing scleritis in a case of Wegener‘s granulomatosis. Ann Ophthalmol. 15(2); 1983: 185-188.
  57. Wang, M., Khurana, RN., Sadda, SR.: Central retinal vein occlusion in Wegener‘s granulomatosis without retinal vasculitis. Br J Ophthalmol. 90(11); 2006: 1435-1436.
  58. WGET Research Group: Design of the Wegener‘s granulomatosis etanercept trial (WGET). Control Clin Trials. 23(4); 2002: 450-468.
  59. Woo, TL., Francis, IC., Wilcsek, GA. et al.: Australasian orbital and adnexal Wegener‘s granulomatosis. Ophthalmology 108(9); 2001: 1535-43.
  60. You, C., Sahawneh, HF., Ma, L., Kubaisi, B. et al.: A review and update on orphan drugs for the treatment of noninfectious uveitis. Clin Ophthalmol. 11; 2017: 257-265.
  61. You, C., Ma, L., Lasave, AF. et al.: Rituximab induction and maintenance treatment in patients with scleritis and granulomatosis with polyangiitis (Wegener‘s). Ocul Immunol Inflamm. 19; 2017: 1-8.